Fengxin Lu
Overview
Explore the profile of Fengxin Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
519
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Solomon D, Giles J, Liao K, Ridker P, Rist P, Glynn R, et al.
Ann Rheum Dis
. 2022 Nov;
82(3):324-330.
PMID: 36450449
Objective: Recent large-scale randomised trials demonstrate that immunomodulators reduce cardiovascular (CV) events among the general population. However, it is uncertain whether these effects apply to rheumatoid arthritis (RA) and if...
2.
Giles J, Rist P, Liao K, Tawakol A, Fayad Z, Mani V, et al.
ACR Open Rheumatol
. 2021 May;
3(6):371-380.
PMID: 33932148
Individuals with rheumatoid arthritis (RA) are at increased risk for atherosclerotic cardiovascular disease (ASCVD) events relative to the general population, potentially mediated by atherosclerotic plaques that are more inflamed and...
3.
Lee Y, Lu F, Colls J, Luo D, Wang P, Dunlop D, et al.
Arthritis Rheumatol
. 2021 Feb;
73(8):1421-1429.
PMID: 33559338
Objective: To examine the effects of a smartphone application (app) to monitor longitudinal electronic patient-reported outcomes (ePROs) on patient satisfaction and disease activity in patients with rheumatoid arthritis (RA). Methods:...
4.
Vanni K, Berliner N, Paynter N, Glynn R, MacFadyen J, Colls J, et al.
ACR Open Rheumatol
. 2020 Nov;
2(12):697-704.
PMID: 33201596
Objective: Low-dose methotrexate (LD-MTX), a cornerstone in the treatment of rheumatoid arthritis, is associated with a moderately increased risk of anemia, leukopenia, and skin cancers, but the risks of myelosuppression...
5.
Colls J, Lee Y, Xu C, Corrigan C, Lu F, Marquez-Grap G, et al.
Rheumatology (Oxford)
. 2020 Jun;
60(1):108-112.
PMID: 32572490
Objectives: Electronic patient-reported outcomes (ePROs) transmitted digitally allow patients to communicate with their clinicians and track the activity of chronic diseases, such as RA. Several ePRO smartphone apps have been...
6.
Solomon D, Glynn R, Karlson E, Lu F, Corrigan C, Colls J, et al.
Ann Intern Med
. 2020 Feb;
172(6):369-380.
PMID: 32066146
Background: Low-dose methotrexate (LD-MTX) is the most commonly used drug for systemic rheumatic diseases worldwide and is the recommended first-line agent for rheumatoid arthritis. Despite extensive clinical use for more...
7.
Kim S, Di Carli M, Garg R, Vanni K, Wang P, Wohlfahrt A, et al.
BMC Rheumatol
. 2019 Mar;
2:17.
PMID: 30886968
Background: Patients with metabolic syndrome (MetS) are at increased risk of asymptomatic hyperuricemia (i.e., elevated serum uric acid (SUA) level without gout) and cardiovascular disease. We conducted a cross-sectional study...
8.
Luo D, Wang P, Lu F, Elias J, Sparks J, Lee Y
J Clin Rheumatol
. 2018 Jun;
25(3):133-141.
PMID: 29933327
Background: Mobile health applications (apps) have the potential to help individuals with chronic illnesses learn about, monitor, and manage their condition, but these apps are largely unexamined, with the state...
9.
Wang P, Luo D, Lu F, Elias J, Landman A, Michaud K, et al.
JMIR Res Protoc
. 2018 Apr;
7(4):e84.
PMID: 29643053
Background: Rheumatoid arthritis flares have a profound effect on patients, causing pain and disability. However, flares often occur between regularly scheduled health care provider visits and are, therefore, difficult to...
10.
Wang P, Smith S, Garg R, Lu F, Wohlfahrt A, Campos A, et al.
RMD Open
. 2018 Mar;
4(1):e000593.
PMID: 29556417
Objectives: Dual-energy CT (DECT) scan is a sensitive and specific tool used to visualise and quantify monosodium urate (MSU) crystal deposits in the joints. Few studies have examined MSU crystal...